DBVT
DBV Technologies S.A.NASDAQHealthcare$21.06+2.73%ClosedMarket Cap: $503.8M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
4.76
P/S
942.28
EV/EBITDA
-3.91
DCF Value
$5.33
FCF Yield
-17.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
-1042.6%
Operating Margin
-20017.3%
Net Margin
-19549.8%
ROE
-189.5%
ROA
-63.0%
ROIC
-77.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-45.7M | $-44.8M | $-1.15 | — |
| FY 2025 | $0.00 | -Infinity% | $-153.2M | $-147.4M | $-5.30 | — |
| Q3 2025 | $0.00 | -Infinity% | $-36.9M | $-33.0M | $-1.60 | — |
| Q2 2025 | $0.00 | -Infinity% | $-43.1M | $-42.4M | $-1.70 | — |
| Q1 2025 | $0.00 | -Infinity% | $-27.4M | $-27.1M | $-1.30 | — |
| Q4 2024 | $511.0K | 100.0% | $-23.9M | $-23.0M | $-1.20 | — |
| FY 2024 | $0.00 | -Infinity% | $-120.5M | $-113.7M | $-5.90 | — |
| Q3 2024 | $1.1M | 100.0% | $-30.3M | $-30.4M | $-1.60 | — |
| Q2 2024 | $0.00 | -Infinity% | $-35.0M | $-33.1M | $-1.70 | — |
| Q1 2024 | $1.4M | 100.0% | $-28.6M | $-27.3M | $-1.40 | — |
| Q4 2023 | $8.9M | 100.0% | $-11.9M | $-11.2M | $-0.60 | — |
| FY 2023 | $15.7M | 100.0% | $-76.4M | $-72.7M | $-3.80 | — |